Medivie Therapeutic Ltd (MDVI) - Total Liabilities

Latest as of June 2021: ILA9.13 Million ILA ≈ $24.49K USD

Based on the latest financial reports, Medivie Therapeutic Ltd (MDVI) has total liabilities worth ILA9.13 Million ILA (≈ $24.49K USD) as of June 2021. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Medivie Therapeutic Ltd - Total Liabilities Trend (2010–2020)

This chart illustrates how Medivie Therapeutic Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore MDVI long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Medivie Therapeutic Ltd Competitors by Total Liabilities

The table below lists competitors of Medivie Therapeutic Ltd ranked by their total liabilities.

Company Country Total Liabilities
Georgina Energy PLC
LSE:GEX
UK GBX3.62 Million
Canyon Creek Food Company Ltd
V:CYF
Canada CA$49.28 Million
Goldplat PLC
LSE:GDP
UK GBX16.02 Million
Corcel PLC
LSE:CRCL
UK GBX5.05 Million
Star Energy Group Plc
LSE:STAR
UK GBX89.39 Million

Liability Composition Analysis (2010–2020)

This chart breaks down Medivie Therapeutic Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Medivie Therapeutic Ltd (MDVI) total assets.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.36 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -2.95 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.95 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medivie Therapeutic Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medivie Therapeutic Ltd (2010–2020)

The table below shows the annual total liabilities of Medivie Therapeutic Ltd from 2010 to 2020.

Year Total Liabilities Change
2020-12-31 ILA8.46 Million
≈ $22.69K
+11.21%
2019-12-31 ILA7.61 Million
≈ $20.40K
+76.26%
2018-12-31 ILA4.32 Million
≈ $11.58K
+25.23%
2017-12-31 ILA3.45 Million
≈ $9.24K
+91.02%
2016-12-31 ILA1.80 Million
≈ $4.84K
+63.35%
2015-12-31 ILA1.10 Million
≈ $2.96K
-35.90%
2014-12-31 ILA1.72 Million
≈ $4.62K
-15.90%
2013-12-31 ILA2.05 Million
≈ $5.50K
+40.70%
2012-12-31 ILA1.46 Million
≈ $3.91K
-84.60%
2011-12-31 ILA9.46 Million
≈ $25.36K
-0.89%
2010-12-31 ILA9.55 Million
≈ $25.59K
--

About Medivie Therapeutic Ltd

TA:MDVI Israel Machinery, Tools, Heavy Vehicles, Trains & Ships
Market Cap
$374.85K
ILA139.82 Million ILA
Market Cap Rank
#31015 Global
#460 in Israel
Share Price
ILA48.60
Change (1 day)
-13.21%
52-Week Range
ILA17.00 - ILA138.00
All Time High
ILA140000.00
About

Medivie Therapeutic Limited develops and markets dental devices. It offers Laboraide, a dental device that is placed between the woman's lower and upper jaw during birth, which allows the relaxation of the jaw, neck, and head muscles through the flow of oxygen to the muscles. The company also develops modular pacifiers that enables development of mouth structure and prevent future damage to the c… Read more